Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
VASCULAR ANOMALIES: Classification and Genetics (Past, Present and Future)
Description
The presentation discusses the evolution of vascular anomalies classification, reflecting on past confusions in terminology, particularly among dermatologists and surgeons. Early classifications led to misunderstandings, but a binary system proposed by Mulliken and Glowacki clarified distinctions between vascular tumors and malformations based on histological characteristics. Subsequent updates recognized complexities, such as the overlap between tumors and malformations and the syndromic nature of some conditions. The advent of genetic studies revealed mutations linked to vascular anomalies, emphasizing the role of genes in both familial and sporadic cases. Recent classifications have begun to incorporate genetic findings, suggesting a new approach that combines genes and phenotypes for categorization. The speaker highlights the challenges of implementing such classifications, as genetic testing is not universally accessible. The discussion culminates in acknowledging that while the new classification framework is a step forward, it cannot fully encompass the diverse and evolving nature of vascular anomalies, which require ongoing adaptation and understanding.
View moreConclusions
- The ISSVA classification promotes clarity in categorizing vascular anomalies based on characteristics and genetics.
- There is increasing recognition of the genetic basis of vascular anomalies, leading to a more precise classification system.
- Boundaries between tumors and vascular malformations are now understood to be less distinct than previously thought.
- Genetic mutations can lead to both tumors and malformations, complicating classification.
- The genetic basis of vascular malformations influences prognosis, treatment, and patient management.
- The new classification emphasizes the need for a clinical foundation in diagnosing vascular anomalies.
- There are significant challenges in implementing the new classification due to variability in genetic mutation detection.
- An evolving understanding of the genetics underlying vascular anomalies will continue to inform future classification efforts.
- Continuous updates in classification systems reflect the complexity and diversity of vascular anomalies.
- C RSE Cardiovasc Intervent Radiol (2019) 42:159 https://doi.org/10.1007/s00270-018-2025-x
- Bruder E. Virchows Arch 454, 161-179 (2009)
- Angela Queisser. Circulation Research. Genetic Basis and Therapies for Vascular Anomalies, Volume: 129, Issue: 1, Pages: 155-173, DOI: (10.1161/CIRCRESAHA.121.318145)
- Ren JG. Hum Pathol. 2017
- Shirley MD. N Engl J Med. 2013 May 23;368(21):1971-9
- Ayturk UM. Am J Hum Genet. 2016 Apr 7;98(4):789-95
- Maari C. J Am Acad Dermatol. 2004
- Lopez-Gutierrez JC and Lapunzina P. Am J Med Genet A. 2008; 146A: 2583-2588
- R. Waelchli et al. BJD 2014, Oct;171(4):861-7
- GNA11 Mutation as a Cause of Sturge-Weber Syndrome: Expansion of the Phenotypic Spectrum of GNA11 Mosaicism and the Associated Clinical Diagnoses Journal of Investigative Dermatology (2020) 140, 1110-1113; doi:10.1016/j.jid.2019.10.019
- Phenotypic Spectrum of GNA11 R183C Mosaicism. Pediatric Dermatology, 2024; 0:1-6